Home
HelpTest Code HIVGR HIV-1 RNA Reverse Transcriptase & Protease & Integrase Genotypic Resistance
Infectious
Additional Codes
LOINC: 80689-3
Specimen Requirements
Preferred:
Specimen Type: Whole blood
Container/Tube: Lavender top (EDTA)
Specimen Volume: 3mL x 4 tubes
Acceptable:
Specimen Type: Plasma
Container/Tube: Sterile container
Specimen Volume: 4mL
Days and Times Performed
TAT 21 working days.
Methodology
Reverse Transcription Polymerase Chain Reaction, High-Throughput Sequencing
Service Code
1033068
Update
Last updated 22/05/2021
Unacceptable Condition
| Whole blood | Frozen or hemolysis |
|---|
Specimen Stability
| Whole blood (EDTA) | 24 hours, ambient/refrigerated (2 - 25 °C) |
|---|---|
| Plasma | Frozen at -20 to -80 °C |
Testing Laboratory
National University Hospital
Molecular Diagnosis Centre, 67724384
Useful For
Identification of HIV-1 drug resistance mutations (DRM) associated with resistance to protease inhibitors, nucleotide reverse transcriptase inhibitors, non-nucleotide reverse transcriptase inhibitors, and integrase inhibitors.
Reference
An interpretative report will be provided.